Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
EUFOREA consensus on biologics for CRSwNP with or without asthmaAllergy (Copenhagen), 2019-12, Vol.74 (12), p.2312-2319 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0105-4538 ;ISSN: 1398-9995 ;EISSN: 1398-9995 ;DOI: 10.1111/all.13875Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Natural products and their derivatives: Promising modulators of tumor immunotherapyJournal of leukocyte biology, 2020-08, Vol.108 (2), p.493-508 [Peer Reviewed Journal]2020 The Authors. published by Wiley Periodicals LLC on behalf of Society for Leukocyte Biology ;2020 The Authors. Journal of Leukocyte Biology published by Wiley Periodicals LLC on behalf of Society for Leukocyte Biology. ;ISSN: 0741-5400 ;EISSN: 1938-3673 ;DOI: 10.1002/JLB.3MR0320-444R ;PMID: 32678943Full text available |
|
3 |
Material Type: Article
|
CalendarInternational wound journal, 2022-08, Vol.19 (5), p.1277 [Peer Reviewed Journal]COPYRIGHT 2022 John Wiley & Sons, Inc. ;ISSN: 1742-4801 ;EISSN: 1742-481X ;DOI: 10.1111/iwj.13881Full text available |
|
4 |
Material Type: Article
|
CalendarInternational wound journal, 2022-08, Vol.19 (5), p.1277 [Peer Reviewed Journal]COPYRIGHT 2022 John Wiley & Sons, Inc. ;ISSN: 1742-4801 ;EISSN: 1742-481X ;DOI: 10.1111/iwj.13881Full text available |
|
5 |
Material Type: Article
|
Considerations on Biologicals for Patients with allergic disease in times of the COVID‐19 pandemic: an EAACI StatementAllergy, 2020-11, Vol.75 (11), p.2764 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;ISSN: 1398-9995 ;EISSN: 1398-9995 ;DOI: 10.1111/all.14407Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s diseaseAlimentary pharmacology & therapeutics, 2020-06, Vol.51 (11), p.1031-1038 [Peer Reviewed Journal]2020 John Wiley & Sons Ltd ;2020 John Wiley & Sons Ltd. ;Copyright © 2020 John Wiley & Sons Ltd ;ISSN: 0269-2813 ;EISSN: 1365-2036 ;DOI: 10.1111/apt.15719 ;PMID: 32329532Full text available |
|
7 |
Material Type: Article
|
From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticalsClinical and experimental immunology, 2016-05, Vol.184 (2), p.137-146 [Peer Reviewed Journal]2016 British Society for Immunology ;2016 British Society for Immunology. ;ISSN: 0009-9104 ;EISSN: 1365-2249 ;DOI: 10.1111/cei.12742 ;PMID: 26597698Full text available |
|
8 |
Material Type: Article
|
Antidrug Antibody Formation in Oncology: Clinical Relevance and ChallengesThe oncologist (Dayton, Ohio), 2016-10, Vol.21 (10), p.1260-1268 [Peer Reviewed Journal]2016 AlphaMed Press ;AlphaMed Press. ;AlphaMed Press 2016 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2016-0061 ;PMID: 27440064Full text available |
|
9 |
Material Type: Article
|
Review article: applying pharmacokinetics to optimise dosing of anti‐TNF biologics in acute severe ulcerative colitisAlimentary pharmacology & therapeutics, 2015-06, Vol.41 (11), p.1094-1103 [Peer Reviewed Journal]2015 John Wiley & Sons Ltd ;2015 John Wiley & Sons Ltd. ;ISSN: 0269-2813 ;EISSN: 1365-2036 ;DOI: 10.1111/apt.13175 ;PMID: 25809869Full text available |
|
10 |
Material Type: Article
|
Synthesis of Natural-Product-Like Molecules with Over Eighty Distinct ScaffoldsAngewandte Chemie (International ed.), 2009-01, Vol.48 (1), p.104-109 [Peer Reviewed Journal]Copyright © 2009 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 2008 ;ISSN: 1433-7851 ;EISSN: 1521-3773 ;DOI: 10.1002/anie.200804486 ;PMID: 19016294Full text available |
|
11 |
Material Type: Article
|
Unlocking the potential of natural products in drug discoveryMicrobial biotechnology, 2019-01, Vol.12 (1), p.55-57 [Peer Reviewed Journal]2018 The Authors. published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2018 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1751-7915 ;EISSN: 1751-7915 ;DOI: 10.1111/1751-7915.13351 ;PMID: 30565871Full text available |
|
12 |
Material Type: Article
|
Adverse side‐effects to biological agentsAllergy (Copenhagen), 2006-08, Vol.61 (8), p.912-920 [Peer Reviewed Journal]ISSN: 0105-4538 ;EISSN: 1398-9995 ;DOI: 10.1111/j.1398-9995.2006.01058.x ;PMID: 16867042Full text available |
|
13 |
Material Type: Article
|
Review of natural product databasesCell proliferation, 2015-08, Vol.48 (4), p.398-404 [Peer Reviewed Journal]2015 John Wiley & Sons Ltd ;2015 John Wiley & Sons Ltd. ;ISSN: 0960-7722 ;EISSN: 1365-2184 ;DOI: 10.1111/cpr.12190 ;PMID: 26009974Full text available |
|
14 |
Material Type: Article
|
The impact and prospect of natural product discovery in agriculture: New technologies to explore the diversity of secondary metabolites in plants and microorganisms for applications in agricultureEMBO reports, 2018-11, Vol.19 (11) [Peer Reviewed Journal]2018 The Authors ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201846824 ;PMID: 30361392Full text available |
|
15 |
Material Type: Article
|
Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA RegistryArthritis & rheumatology (Hoboken, N.J.), 2014-09, Vol.66 (9), p.2580-2589 [Peer Reviewed Journal]Copyright © 2014 by the American College of Rheumatology ;Copyright © 2014 by the American College of Rheumatology. ;ISSN: 2326-5191 ;EISSN: 2326-5205 ;DOI: 10.1002/art.38741 ;PMID: 24942886Full text available |
|
16 |
Material Type: Article
|
Plant natural products: from traditional compounds to new emerging drugs in cancer therapyCell proliferation, 2014-12, Vol.47 (6), p.506-515 [Peer Reviewed Journal]2014 John Wiley & Sons Ltd ;2014 John Wiley & Sons Ltd. ;ISSN: 0960-7722 ;EISSN: 1365-2184 ;DOI: 10.1111/cpr.12143 ;PMID: 25377084Full text available |
|
17 |
Material Type: Article
|
Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s diseaseAlimentary pharmacology & therapeutics, 2020-05, Vol.51 (9), p.831-842 [Peer Reviewed Journal]2020 John Wiley & Sons Ltd ;2020 John Wiley & Sons Ltd. ;Copyright © 2020 John Wiley & Sons Ltd ;ISSN: 0269-2813 ;EISSN: 1365-2036 ;DOI: 10.1111/apt.15685 ;PMID: 32202328Full text available |
|
18 |
Material Type: Article
|
One‐year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healingAlimentary pharmacology & therapeutics, 2019-04, Vol.49 (8), p.1026-1039 [Peer Reviewed Journal]2019 John Wiley & Sons Ltd ;2019 John Wiley & Sons Ltd. ;Copyright © 2019 John Wiley & Sons Ltd ;ISSN: 0269-2813 ;EISSN: 1365-2036 ;DOI: 10.1111/apt.15190 ;PMID: 30854708Full text available |
|
19 |
Material Type: Article
|
Process intensification to produce a difficult-to-express therapeutic enzyme by high cell density perfusion or enhanced fed-batchBiotechnology and bioengineering, 2021-09, Vol.118 (9), p.3533 [Peer Reviewed Journal]ISSN: 1097-0290 ;ISSN: 0006-3592 ;EISSN: 1097-0290 ;DOI: 10.1002/bit.27806Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agentsBritish journal of pharmacology, 2010-06, Vol.160 (4), p.810-820 [Peer Reviewed Journal]2010 The Author. Journal compilation © 2010 The British Pharmacological Society ;2015 INIST-CNRS ;Journal compilation © 2010 The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/j.1476-5381.2010.00702.x ;PMID: 20590580 ;CODEN: BJPCBMFull text available |